COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,435 Articles (22,835 medRxiv, 8,600 bioRxiv)

Most recent first Previous |  Page 1498: Articles 14971-14980  | Next

Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike Protein after Natural Infection or COVID-19 vaccination
Sariol, C. A., Pantoja, P., Serrano-Collazo, C., Rosa-Arocho, T., Armina, A., Cruz, L., Stone, E. T., Arana, T., Climent, C., Latoni, G., Atheortua, D., Pabon-Carrero, C., Pinto, A. K., Brien, J. D., Espino, A. M.
10.1101/2021.06.02.21257975 — Posted: 2021-06-03
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
Phetsouphanh, C., Darley, D., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., Kelleher, A. D., Matthews, G.
10.1101/2021.06.01.21257759 — Posted: 2021-06-03
Interim estimates of increased transmissibility, growth rate, and reproduction number of the Covid-19 B.1.617.2 variant of concern in the United Kingdom
Dagpunar, J. S.
10.1101/2021.06.03.21258293 — Posted: 2021-06-03 Discussion: Onsite
Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients
Diefenbach, C., Caro, J., Koide, A., Grossbard, M., Goldberg, J., Raphael, B., Hymes, K., Moskovits, T., Kreditor, M., Kaminetzky, D., Saint-Fleur Lominy, S., Choi, J., Thannickal, S., Stapleford, K., Koide, S.
10.1101/2021.06.02.21257804 — Posted: 2021-06-03
COVID-19 Sniffer Dog experimental training: which protocol and which implications for reliable identification?
Angeletti, S., Travaglino, F., Spoto, S., Pascarella, M. C., Mansi, G., De Cesaris, M., Sartea, S., Giovanetti, M., Fogolari, M., Plescia, D., Macera, M., Antonelli Incalzi, R., Ciccozzi, M.
10.1101/2021.06.02.21257981 — Posted: 2021-06-03
Irradiation of UVC LED at 277 nm inactivates coronaviruses by photodegradation of spike protein.
Ong, Q., Teo, J. W. R., Dela Cruz, J., Wee, E., Wee, W., Han, W.
10.1101/2021.05.31.446403 — Posted: 2021-06-03
Tracing contacts to evaluate the transmission of COVID-19 from highly exposed individuals in public transportation
Ponte, C., Carmona, H., Oliveira, E., Caminha, C., Lima Neto, A., Andrade, J., Furtado, V.
10.1101/2021.05.31.21257245 — Posted: 2021-06-03
Effects of the COVID-19 pandemic on publication landscape in chimeric antigen receptor-modified immune cell research
Yu, J., Yilmaz, A.
10.1101/2021.06.01.446639 — Posted: 2021-06-02
Immune dynamics in a time of covid
Shinbrot, T.
10.1101/2021.06.01.446677 — Posted: 2021-06-02
Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales
Miller, F., Nguyen, V., Navaratnam, A. M., Shrotri, M., Kovar, J., Hayward, A. C., Fragaszy, E., Aldridge, R. W., Virus Watch Collaborative, , Hardelid, P.
10.1101/2021.05.28.21257602 — Posted: 2021-06-02 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).